Thomas Wakim
Stock Analyst at Bell Potter
(0.39)
# 4,407
Out of 4,792 analysts
112
Total ratings
46.3%
Success rate
-6.4%
Average return
Main Sectors:
Stocks Rated by Thomas Wakim
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: CUV Clinuvel Pharmaceuticals Limited | Downgraded: Hold | $17.00 → $11.50 | $8.01 | +43.57% | 6 | Aug 27, 2026 | |
| ASX: NEU Neuren Pharmaceuticals Limited | Reiterated: Buy | $25.50 | $20.21 | +26.18% | 17 | Aug 27, 2026 | |
| ASX: ALC Alcidion Group Limited | Reiterated: Buy | $0.15 | $0.11 | +42.86% | 15 | Aug 20, 2026 | |
| ASX: CGS Cogstate Limited | Reiterated: Buy | $3.70 | $3.01 | +22.92% | 7 | Aug 19, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Hold | $120.00 → $150.00 | $169.50 | -11.50% | 11 | Aug 19, 2026 | |
| ASX: ATX Amplia Therapeutics Limited | Reiterated: Buy | $0.42 | $0.12 | +250.00% | 3 | Aug 5, 2026 | |
| ASX: PYC PYC Therapeutics Limited | Reiterated: Buy | $2.30 | $2.32 | -0.86% | 8 | Jul 30, 2026 | |
| ASX: SNT Syntara Limited | Reiterated: Buy | $0.06 | $0.02 | +150.00% | 7 | Jul 28, 2026 | |
| ASX: MAP Microba Life Sciences Limited | Downgraded: Hold | $0.12 → $0.05 | $0.06 | -10.71% | 13 | Jul 16, 2026 | |
| ASX: GSS Genetic Signatures Limited | Downgraded: Hold | $0.55 → $0.10 | $0.08 | +20.48% | 8 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.65 → $0.07 | $0.04 | +59.09% | 8 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.09 → $0.10 | $0.01 | n/a | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1.30 → $0.05 | $0.01 | n/a | 4 | Apr 1, 2025 |
Clinuvel Pharmaceuticals Limited
Aug 27, 2026
Downgraded: Hold
Price Target: $17.00 → $11.50
Current: $8.01
Upside: +43.57%
Neuren Pharmaceuticals Limited
Aug 27, 2026
Reiterated: Buy
Price Target: $25.50
Current: $20.21
Upside: +26.18%
Alcidion Group Limited
Aug 20, 2026
Reiterated: Buy
Price Target: $0.15
Current: $0.11
Upside: +42.86%
Cogstate Limited
Aug 19, 2026
Reiterated: Buy
Price Target: $3.70
Current: $3.01
Upside: +22.92%
CSL Limited
Aug 19, 2026
Reiterated: Hold
Price Target: $120.00 → $150.00
Current: $169.50
Upside: -11.50%
Amplia Therapeutics Limited
Aug 5, 2026
Reiterated: Buy
Price Target: $0.42
Current: $0.12
Upside: +250.00%
PYC Therapeutics Limited
Jul 30, 2026
Reiterated: Buy
Price Target: $2.30
Current: $2.32
Upside: -0.86%
Syntara Limited
Jul 28, 2026
Reiterated: Buy
Price Target: $0.06
Current: $0.02
Upside: +150.00%
Microba Life Sciences Limited
Jul 16, 2026
Downgraded: Hold
Price Target: $0.12 → $0.05
Current: $0.06
Upside: -10.71%
Genetic Signatures Limited
Apr 7, 2026
Downgraded: Hold
Price Target: $0.55 → $0.10
Current: $0.08
Upside: +20.48%
Mar 16, 2026
Downgraded: Hold
Price Target: $0.65 → $0.07
Current: $0.04
Upside: +59.09%
May 13, 2025
Reiterated: Hold
Price Target: $0.09 → $0.10
Current: $0.01
Upside: n/a
Apr 1, 2025
Downgraded: Sell
Price Target: $1.30 → $0.05
Current: $0.01
Upside: n/a